Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML
Clinical trial NCT07486479 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07486479
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-10
- Primary completion
- 2026-12-31
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.